Optimising the management of relapsed/refractory AML: Perspectives from Clinical Nurse Specialists
12 May 2022
About the event
This interactive webinar focuses on the optimal management of relapsed/refractory (R/R) acute myeloid leukaemia (AML); providing practical guidance for AML clinical nurse specialists in the UK. Cara Manson will outline the current management of AML and provide a case study of an elderly patient unfit for intensive chemotherapy; highlighting the nurses role. Liz Brown will explore the nurses role in providing psychological support for patients with AML and Cara Manson will then discuss monitoring and managing adverse events in the clinic. This webinar features three Q&A sessions for the discussion of practical issues.
At Astellas, being at the forefront of healthcare change means tackling the toughest health challenges by putting people at the heart of every decision we make. Through a focus on the people we serve, we convert brilliant science into treatments and solutions that improve and save patients’ lives, in disease areas others often don’t.
